Current Edition

Going Mobile with Clinical Trials
Editorial Archive

Going Mobile with Clinical Trials

Liz Logan, Head of the MCT-Congress, gives Journal for Clinical Studies an insight into the business of mobile technology in the clinical trial space, and shares her ...
Continue Reading →
Safe and Secure: How Digital technology is Revolutionizing Patient Privacy
Editorial Archive

Safe and Secure: How Digital technology is Revolutionizing Patient Privacy

Digitalization of healthcare is unstoppable, as it provides increased adherence, better health outcomes and - ultimately - billions of pounds saved worldwide. However...
Continue Reading →
Clinical Trial Data Analysis – Optimising Services in a Globally Distributed Model
Editorial Archive

Clinical Trial Data Analysis – Optimising Services in a Globally Distributed Model

The growing complexities of the drug development process, toughening drug safety standards, increased regulatory scrutiny, and ongoing patent cliff have placed signif...
Continue Reading →
Improving Data Quality for Risk-Based Monitoring and Data Review
Editorial Archive

Improving Data Quality for Risk-Based Monitoring and Data Review

With continued efforts to improve clinical processes, risk-based monitoring (RBM) approaches are becoming increasingly important for sponsors and CROs. Petra Cramer o...
Continue Reading →
Compliance and Quality Improvement Issues in Behavioural Healthcare today
Editorial Archive

Compliance and Quality Improvement Issues in Behavioural Healthcare today

In recent years, behavioural health agencies have begun to apply the outcomes-based measurements found in medicine to improve their ability to meet compliance standar...
Continue Reading →
Drug Accountability and Destruction Reporting – Closing the Clinical Supply Chain Information Loop
Editorial Archive

Drug Accountability and Destruction Reporting – Closing the Clinical Supply Chain Information Loop

Martin Lamb of Biotec Services International proves there are ways in which a little extra time spent on up-front planning of clinical supply accountability can save ...
Continue Reading →
Biosimilars: Experience to Date and the Potential to Improve Access in the United States
Editorial Archive

Biosimilars: Experience to Date and the Potential to Improve Access in the United States

Currently, the global biosimilars market includes monoclonal antibody (mAb) biosimilars for the treatment of cancer and autoimmune conditions (e.g., rheumatoid arthri...
Continue Reading →
Increased Awareness of Indian Population of Common Skin Conditions and Its Impact on Clinical Research: An Insight
Editorial Archive

Increased Awareness of Indian Population of Common Skin Conditions and Its Impact on Clinical Research: An Insight

Owing to a large population base, the prevalence of various dermatological disorders in India is fairly high, even for uncommon disorders. Vandana Mungroo Beechoo and...
Continue Reading →
Clinical Research in the United Arab Emirates
Editorial Archive

Clinical Research in the United Arab Emirates

With a bustling population composed of a mixture of expats and locals, and the topic of clinical research not being so popular among the crowd, the phenomenon of clin...
Continue Reading →
Go Beyond South Africa – North Africa (Francophonic Countries) Being the Next Generation Clinical Trial Destination in Africa
Editorial Archive

Go Beyond South Africa – North Africa (Francophonic Countries) Being the Next Generation Clinical Trial Destination in Africa

Currently more than 45% of the whole continent's clinical trials are being conducted in South Africa, hence the need for pharmaceutical companies to identify the next...
Continue Reading →